Bafna Pharmaceuticals Ltd — Quarterly Results & Earnings

₹109.34

-4.38%

Profit Growth YoY19.08%Latest quarter

Sales Growth YoY-12.03%Latest quarter

Sales CAGR 5Y27.99%5 year compound

Profit CAGR 5Y40.15%5 year compound

📋

Quarterly Performance

YoY Profit Growth+19.08%

✅ Strong growth

YoY Sales Growth-12.03%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

10.58%

EPS Growth 5Y

18.54%

Interest Coverage

Higher = safer debt servicing

4.27

ROE

7.69%

ROCE

8.34%

💡

Growth Analysis

Bafna Pharmaceuticals Ltd reported YoY profit growth of 19.08% and revenue growth of -12.03% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 27.99% and profits at 40.15% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Bafna Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.